Literature DB >> 26154422

Impact of Gap Junctional Intercellular Communication on MLO-Y4 Sclerostin and Soluble Factor Expression.

S L York1, P Sethu2, M M Saunders3.   

Abstract

Bone remodeling is a continual process in which old bone is resorbed by osteoclasts and new bone is formed by osteoblasts, providing a mechanism for bones' ability to adapt to changes in its mechanical environment. While the role of osteoblasts and osteoclasts in bone remodeling is well understood, the cellular regulation of bone remodeling is unclear. One theory is that osteocytes, found within bone, play an important role in controlling the bone remodeling response. Osteocytes possess gap junctions, narrow channels that extend between nearby cells and allow communication between cells via the transfer of small molecules and ions. This work investigated the potential role of gap junctional intercellular communication in bone remodeling by exposing osteocyte-like MLO-Y4 cells to mechanical strains and quantifying the expression of soluble factors, including sclerostin, a protein closely associated with bone remodeling. The soluble factors and sclerostin expression were further examined after inhibiting gap junctional intercellular communication to study the impact of the communication. At supraphysiologic strains, the inhibition of gap junctional intercellular communication led to increases in sclerostin expression relative to cells in which communication was present, indicating that the communication may play a significant role in regulating bone remodeling.

Entities:  

Keywords:  Cell–cell communication; In vitro; Mechanotransduction; Osteocyte; Soluble factors

Mesh:

Substances:

Year:  2015        PMID: 26154422      PMCID: PMC4706514          DOI: 10.1007/s10439-015-1376-6

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  25 in total

Review 1.  Techniques for mechanical stimulation of cells in vitro: a review.

Authors:  T D Brown
Journal:  J Biomech       Date:  2000-01       Impact factor: 2.712

2.  Exercise-induced bone gain is due to enlargement in bone size without a change in volumetric bone density: a peripheral quantitative computed tomography study of the upper arms of male tennis players.

Authors:  H Haapasalo; S Kontulainen; H Sievänen; P Kannus; M Järvinen; I Vuori
Journal:  Bone       Date:  2000-09       Impact factor: 4.398

3.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 4.  Mechanisms of mechanotransduction.

Authors:  A Wayne Orr; Brian P Helmke; Brett R Blackman; Martin A Schwartz
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

5.  Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.

Authors:  Chuwen Lin; Xuan Jiang; Zhongquan Dai; Xizhi Guo; Tujun Weng; Jun Wang; Yinghui Li; Guoyin Feng; Xiang Gao; Lin He
Journal:  J Bone Miner Res       Date:  2009-10       Impact factor: 6.741

Review 6.  The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone.

Authors:  A M Parfitt
Journal:  Calcif Tissue Int       Date:  1984       Impact factor: 4.333

7.  Osteoblast-specific Angiopoietin 1 overexpression increases bone mass.

Authors:  Toru Suzuki; Takeshi Miyamoto; Nobuyuki Fujita; Ken Ninomiya; Ryotaro Iwasaki; Yoshiaki Toyama; Toshio Suda
Journal:  Biochem Biophys Res Commun       Date:  2007-08-28       Impact factor: 3.575

8.  Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Authors:  Marc Baud'huin; Laurence Duplomb; Stéphane Téletchéa; Céline Charrier; Mike Maillasson; Marc Fouassier; Dominique Heymann
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

9.  A soluble activin type IIA receptor induces bone formation and improves skeletal integrity.

Authors:  R Scott Pearsall; Ernesto Canalis; Milton Cornwall-Brady; Kathryn W Underwood; Brendan Haigis; Jeffrey Ucran; Ravindra Kumar; Eileen Pobre; Asya Grinberg; Eric D Werner; Vaida Glatt; Lisa Stadmeyer; Deanna Smith; Jasbir Seehra; Mary L Bouxsein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-06       Impact factor: 11.205

10.  Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.

Authors:  Alexander G Robling; Paul J Niziolek; Lee A Baldridge; Keith W Condon; Matthew R Allen; Imranul Alam; Sara M Mantila; Jelica Gluhak-Heinrich; Teresita M Bellido; Stephen E Harris; Charles H Turner
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

View more
  4 in total

1.  Connexin43 enhances Wnt and PGE2-dependent activation of β-catenin in osteoblasts.

Authors:  Aditi Gupta; Saimai Chatree; Atum M Buo; Megan C Moorer; Joseph P Stains
Journal:  Pflugers Arch       Date:  2019-06-25       Impact factor: 3.657

Review 2.  Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy.

Authors:  Sarah-Kim Bisson; Roth-Visal Ung; Fabrice Mac-Way
Journal:  Int J Endocrinol       Date:  2018-04-02       Impact factor: 3.257

3.  Osteocytic cells exposed to titanium particles increase sclerostin expression and inhibit osteoblastic cell differentiation mostly via direct cell-to-cell contact.

Authors:  Hao Chai; Zai Hang Zhang; Jing Yi Fang; Chang She; De Chun Geng; Wei Xu
Journal:  J Cell Mol Med       Date:  2022-06-28       Impact factor: 5.295

4.  Effects of BDNF and PEC Nanoparticles on Osteocytes.

Authors:  Thomas Leonhard Loy; David Vehlow; Vivien Kauschke; Martin Müller; Christian Heiss; Katrin Susanne Lips
Journal:  Molecules       Date:  2020-09-10       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.